WVP
NVNO

Worth Venture Partners’s enVVeno Medical NVNO Stock Holding History

Worth Venture Partners’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,368
Closed -$569K – 136
2021
Q2 		$569K Sell
2,368
-510
-18% -$109K 0.21% 86
2021
Q1 		$671K Buy
+2,878
New +$801K 0.33% 72

Other funds holding NVNO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LSA
L & S Advisors Los Angeles, California $795M AUM 52.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Worth Venture Partners's NVNO Position: Q3 2021 in Review

Worth Venture Partners sold out of enVVeno Medical (NVNO) in Q3 2021, closing a stake of 2,368 shares — an estimated $569K sold.

Worth Venture Partners first reported a position in NVNO in Q1 2021 and held it in 2 quarters. The position peaked at $671K in Q1 2021. 15 funds tracked by Wall St. Rank hold NVNO as of Q3 2021.

  • Worth Venture Partners reported no remaining enVVeno Medical position as of Q3 2021 after selling out during the quarter.
  • Worth Venture Partners sold 2,368 enVVeno Medical shares in Q3 2021, an estimated $569K.
  • Worth Venture Partners first reported a position in enVVeno Medical in Q1 2021 and held it in 2 quarters.
  • Worth Venture Partners's enVVeno Medical position peaked at $671K in Q1 2021.
  • 15 funds tracked by Wall St. Rank held enVVeno Medical as of Q3 2021.

Based on Worth Venture Partners's 13F filing for Q3 2021, filed 15 Nov 2021.